“Translational research on cancer epigenetics”
The expected outcome of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.
For further information, please visit our dedicated JTC 2023 Webpage.
Timeline of the Call
9 May 2023 | Publication of the call |
29 May 2023 at 16:00 (CEST) | Opening of the on-line submission system for pre-proposals |
21 July 2023 at 12:00 (CEST) | Deadline for pre-proposal submission |
27 October 2023 | Communication of the results of the pre-proposal assessment and invitation for full-proposal stage |
13 November 2023 | Opening of the submission system for full proposals |
15 December 2023 at 12:00 (CET) | Deadline for full-proposal submission |
Expected for May 2024 | Communication of the funding decisions to the applicants |
September 2024 | Expected project start (also subject to regional/national procedures) |